Cerus Corp
NASDAQ:CERS
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.52
2.42
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Cerus Corp
Gross Margin
Cerus Corp
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | US |
| Market Cap | 332.3m USD |
| Gross Margin |
61%
|
| Country | JP |
| Market Cap | 6.8T JPY |
| Gross Margin |
86%
|
| Country | CH |
| Market Cap | 37.9B CHF |
| Gross Margin |
55%
|
| Country | DK |
| Market Cap | 200.9B DKK |
| Gross Margin |
68%
|
| Country | US |
| Market Cap | 16.9B USD |
| Gross Margin |
70%
|
| Country | KR |
| Market Cap | 9.9T KRW |
| Gross Margin |
15%
|
| Country | CA |
| Market Cap | 6.9B USD |
| Gross Margin |
61%
|
| Country | CN |
| Market Cap | 48.6B CNY |
| Gross Margin |
73%
|
| Country | US |
| Market Cap | 6.3B USD |
| Gross Margin |
65%
|
| Country | US |
| Market Cap | 6.1B USD |
| Gross Margin |
47%
|
| Country | UK |
| Market Cap | 4.8B GBP |
| Gross Margin |
56%
|
Cerus Corp
Glance View
Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The company is headquartered in Concord, California and currently employs 294 full-time employees. The company is focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, which is based on its technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Its INTERCEPT Blood System is intended for use with blood components and certain of their derivatives, such as plasma, platelets, red blood cells. Its product or product candidates under development includes INTERCEPT Blood System-Platelets, INTERCEPT Blood System-Plasma, INTERCEPT Blood System-Red Blood Cells and INTERCEPT Blood System-Cryoprecipitation. The INTERCEPT Blood System is designed to target and inactivate blood-borne pathogens, such as viruses, bacteria and parasites, as well as potentially harmful white blood cells, while preserving the therapeutic properties of platelet, plasma and red blood cell transfusion products.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Cerus Corp's most recent financial statements, the company has Gross Margin of 60.5%.
You don't have any saved screeners yet
